CN1450995A - 用于治疗青光眼的5－羟基吲唑衍生物 - Google Patents

用于治疗青光眼的5－羟基吲唑衍生物 Download PDF

Info

Publication number
CN1450995A
CN1450995A CN00819348A CN00819348A CN1450995A CN 1450995 A CN1450995 A CN 1450995A CN 00819348 A CN00819348 A CN 00819348A CN 00819348 A CN00819348 A CN 00819348A CN 1450995 A CN1450995 A CN 1450995A
Authority
CN
China
Prior art keywords
alkyl
hydrogen
indazole
aminopropyl
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00819348A
Other languages
English (en)
Chinese (zh)
Inventor
J·A·梅
冯子侠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Alcon Universal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Universal Ltd filed Critical Alcon Universal Ltd
Publication of CN1450995A publication Critical patent/CN1450995A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN00819348A 2000-03-17 2000-11-14 用于治疗青光眼的5－羟基吲唑衍生物 Pending CN1450995A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19028300P 2000-03-17 2000-03-17
US60/190,283 2000-03-17

Publications (1)

Publication Number Publication Date
CN1450995A true CN1450995A (zh) 2003-10-22

Family

ID=22700701

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00819348A Pending CN1450995A (zh) 2000-03-17 2000-11-14 用于治疗青光眼的5－羟基吲唑衍生物

Country Status (12)

Country Link
EP (1) EP1268439A1 (enExample)
JP (1) JP2003535821A (enExample)
KR (1) KR20030095183A (enExample)
CN (1) CN1450995A (enExample)
AR (1) AR026708A1 (enExample)
AU (2) AU1918001A (enExample)
BR (1) BR0017163A (enExample)
CA (1) CA2401959A1 (enExample)
MX (1) MXPA02008825A (enExample)
PL (1) PL365422A1 (enExample)
WO (1) WO2001070701A1 (enExample)
ZA (1) ZA200206853B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
JP2004535418A (ja) 2001-06-01 2004-11-25 アルコン，インコーポレイテッド ピラノインダゾールおよび緑内障治療への使用
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
CN100384827C (zh) * 2002-11-08 2008-04-30 默克公司 用于治疗高眼压症的眼用组合物
US7196082B2 (en) * 2002-11-08 2007-03-27 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
WO2004043354A2 (en) 2002-11-08 2004-05-27 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
EP1581209A4 (en) 2002-12-13 2009-03-11 Alcon Inc NEW BENZOPYRAN ANALOGUE AND ITS USE FOR THE TREATMENT OF GLAUKOM
JP2004262812A (ja) * 2003-02-28 2004-09-24 Rohto Pharmaceut Co Ltd 眼圧低下剤
US7494983B2 (en) * 2003-09-04 2009-02-24 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
WO2005058911A2 (en) 2003-12-15 2005-06-30 Alcon, Inc. Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
AP2007004024A0 (en) 2004-11-29 2007-06-30 Warner Lambert Co Therapeutic pyrazoloÄ3,4-BÜpyridines and indazoles
US7425572B2 (en) 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
KR100972921B1 (ko) * 2009-12-02 2010-07-28 제이케이이앤씨 주식회사 회전 격판식 선회류 세정 및 탈취장치
WO2025000053A1 (en) 2023-06-28 2025-01-02 Psylo Pty Ltd Compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
JP2002515408A (ja) * 1998-05-19 2002-05-28 アルコン ラボラトリーズ， インコーポレーテッド 眼および中枢神経系疾患治療用セロトニン作動性５ｈｔ７受容体化合物
GB9819020D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds III
TR200100754T2 (tr) * 1998-09-18 2001-10-22 Alcon Laboratories, Inc. Glausomanın tedavi edilmesi için serotonerjik 5HT2.

Also Published As

Publication number Publication date
EP1268439A1 (en) 2003-01-02
AR026708A1 (es) 2003-02-26
BR0017163A (pt) 2003-01-14
JP2003535821A (ja) 2003-12-02
AU2001219180B2 (en) 2005-04-07
MXPA02008825A (es) 2004-10-15
PL365422A1 (en) 2005-01-10
AU1918001A (en) 2001-10-03
KR20030095183A (ko) 2003-12-18
CA2401959A1 (en) 2001-09-27
WO2001070701A1 (en) 2001-09-27
ZA200206853B (en) 2004-11-02

Similar Documents

Publication Publication Date Title
CN1450995A (zh) 用于治疗青光眼的5－羟基吲唑衍生物
US6956036B1 (en) 6-hydroxy-indazole derivatives for treating glaucoma
CN1450994A (zh) 用于治疗青光眼的6－羟基－吲唑衍生物
WO2001070705A1 (en) 2-acylaminobenzimidazole derivatives for treating glaucoma
CN1325399A (zh) 作为5－ht2c兴奋剂的吡咯并吲哚、吡啶并吲哚和氮杂草并吲哚
CN1044910C (zh) 吲哚衍生物
AU2001219180A1 (en) 5-hydroxy indazole derivatives for treating glaucoma
AU2002259312B2 (en) Novel arylaminopropane analogues and their use for the treatment of glaucoma
CN1780615A (zh) 氮杂环丁烷羧酰胺衍生物在疗法中的用途
WO2001040183A1 (en) 1-aminoalkyl-1h-indoles for treating glaucoma
JP2004532887A (ja) 新規な融合インダゾールおよびインドールおよび緑内障治療へのこれらの使用
US6806285B1 (en) 5-Hydroxyl indole derivatives for treating glaucoma
CN1301161A (zh) 用于治疗眼睛和中枢神经系统障碍的血清素激活的5ht7受体化合物
CN1268334C (zh) 新颖的苯并二呋喃咪唑啉和苯并呋喃咪唑啉衍生物及其用于制备治疗青光眼药物的用途
CN1203072C (zh) 用于治疗青光眼的吡喃并吲哚
EP1581209A2 (en) Novel benzopyran analogs and their use for the treatment of glaucoma
CN1293066C (zh) 反式稠合的3,3a,8,12b－四氢－2H－二苯并[3,4∶6,7]环庚三烯并[1,2－b]呋喃衍生物的制备
CN1133843A (zh) 噻吩并吡啶酮
US7005443B1 (en) 5-Hydroxy indazole derivatives for treating glaucoma
CN1279609A (zh) 选择性5－HT1A拮抗剂和选择性h5－HT1B拮抗剂或部分激动剂的组合物
CN1697833A (zh) 顺式－稠合的3,3a,8,12b－四氢－2H－二苯并[3,4:6,7]环庚并[1,2－b]呋喃衍生物的制备方法
WO2001070686A1 (en) 5-hydroxy indole derivatives for treating glaucoma
CN1127501C (zh) 吲哚和2,3－二氢吲哚衍生物、它们的制备及用途
HK1050897B (en) Pyranoindoles for treating glaucoma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication